Compare drug alternatives
Ubrelvy® Alternatives
Ubrelvy®
(ubrogepant)
Ubrelvy
-
Migraine
- Emgality®
- Vyepti®
- Aimovig®
- Ajovy®
- Nurtec ODT®
Prescription Only
Ubrelvy is a medication that adults can use to treat acute migraine attacks. It works by blocking CGRP, a protein believed to contribute to migraine attacks by causing pain, blood vessel dilation, and inflammation. Ubrelvy is well-tolerated, with less than 5% of individuals reporting side effects such as nausea, somnolence, and dry mouth. Ubrelvy does not prevent migraines.
Ubrelvy is FDA approved for the following indications: Migraine.
Qulipta®
(Atogepant)
Qulipta
-
Migraine
- Emgality®
- Vyepti®
- Aimovig®
- Ajovy®
- Nurtec ODT®
Prescription Only
Qulipta is a prescription medication that is used as a preventative treatment for episodic migraines. It is a tablet that is taken once daily. The most common side effects are fatigue, nausea, and constipation.
Qulipta is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Oral
Oral
Dosing
50 mg or 100 mg as needed. Maximum daily dose: 200 mg. Severe Hepatic or Severe Renal Impairment: 50 mg.
10 mg, 30 mg, or 60 mg once daily. Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.
Latin Shorthand
50 mg PRN or 100 mg PNR. Severe Renal Impairment: 50mg.
10mg qd, 30mg qd or 60mg qd
Renal Impairment: 10mg qd
Financial Assistance
Copay
$0
$0
Annual Cap
Maximum savings of $50 per pill for up to 13 prescription fills.
$6,000
Assistance Expiration
13 prescription fills
12 30-day prescription fills
Generics
No lower-cost generic available
No lower-cost generic available